Success Story: Despite RFE, EB1A Approval for a Ph.D. Candidate from Iran in Under 4 Months Under Premium Processing

Posted by wegreened on January 30, 2026 in EB1 Green Card, Technology (Nanotechnology, Nanoscience, Biomaterials, Biomechanics, Biomedical Engineering, Bioinformatics, Bioengineering, Biomedical Science, Biotechnologies)

Client’s Testimonial:

“Thank you for your message, and I truly appreciate all the support your team has provided throughout this process.”

On November 14^th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Ph.D. Candidate in the Field of Biomaterials (Approval Notice).

General Field: Biomaterials

Position at the Time of Case Filing: PhD Candidate

Country of Origin: Iran

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: November 14^th, 2025

Processing Time: 3 months 21 days (Premium Processing Requested)

Case Summary:

Our firm celebrates the approval of an EB-1A (Alien of Extraordinary Ability) petition for a Ph.D. candidate in the field of biomaterials from Iran. Despite receiving a Request for Evidence, the petition was approved in just over 3 months under premium processing with our assistance.

Client Profile and Expertise

The client, holding an M.Sc. and B.Sc. in Polymer Engineering, has emerged as a pioneering voice in biomaterials for tissue engineering and regenerative medicine. His groundbreaking research encompasses engineering dynamic hydrogels that enhance cell-material interactions, merging nanotechnology with regenerative medicine to advance wound healing applications, and architecting innovative biomaterials for next-generation drug delivery systems.

Our Strategic Approach

Leveraging our extensive portfolio of over 32,000 successful cases, our expert team meticulously constructed a compelling narrative that showcased:

13 peer-reviewed journal articles (6 first-authored) and 1 preprint published in elite venues
722 citations from researchers across the globe, positioning the client within the top 1% most highly cited authors
16 peer reviews for distinguished journals, evidencing widely recognized expertise
Prestigious funding from leading organizations, including the National Institutes of Health (NIH), the National Science Foundation (NSF), the American Heart Association (AHA), the Natural Sciences and Engineering Research Council of Canada (NSERC), Henry Ford Health, the Estonian Research Council, and the Federal Ministry of Education and Research of Germany.

We secured 4 powerful recommendation letters. One expert has stated that:

“His work directly benefits American industries and academia, considering the importance put on cancer treatment and drug research.“

Successful Outcome

Considering the strength of the client’s accomplishments and our comprehensive petition strategy, we are delighted to report that the EB-1A petition was approved, affirming the client’s status among the elite percentage at the pinnacle of his field. It has been an honor to support this extraordinary researcher throughout this journey, and we extend our sincere best wishes for his continued success in advancing American leadership in biotechnology and biomedical innovation while contributing transformative solutions to critical healthcare challenges.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%